Published 2018
| Version v1
Publication
Subcutaneous immunoglobulins are a valuable treatment option in myasthenia gravis
Additional details
Identifiers
- URL
- http://hdl.handle.net/11567/891418
- URN
- urn:oai:iris.unige.it:11567/891418
Origin repository
- Origin repository
- UNIGE